Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added: 2023 ( U.S. NIH Grant/Contract ) and Revision: v3.6.6. Deleted: Multiple myeloma, related topics: MedlinePlus Genetics, and Revision: v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-31T02:58:25.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now includes related topics tags for 'Multiple myeloma' and 'MedlinePlus Genetics', linking the study to related resources and improving navigation.
    Difference
    0.1%
    Check dated 2026-08-24T01:45:35.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Adds a complete HTML snippet for an error page (doctype, head, body with 'An error occurred' and 'page is currently unavailable'), including site header/footer elements. This represents a non-content/error state rather than substantive study data.
    Difference
    22%
    Check dated 2026-08-10T01:50:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page no longer mentions the disease name and the related topics section; this removes explicit disease context and a related resources reference from the study details.
    Difference
    0.1%
    Check dated 2026-08-03T05:51:42.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now explicitly mentions Multiple myeloma and adds a related topics section with a MedlinePlus Genetics link; the site revision tag updates from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-27T03:28:00.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Adds the study title, EU CTIS number, and new dates for primary completion (2028-03-25) and study completion (2032-03-24). Also clarifies the cohort-based design, updated eligibility criteria, and drug administration details for the linvoseltamab-based regimens.
    Difference
    2%
    Check dated 2026-07-13T02:27:53.000Z thumbnail image

Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.